Cardiovascular Systems Inc 4
4 · Cardiovascular Systems Inc · Filed Mar 2, 2017
Insider Transaction Report
Form 4
Koehn Paul A
VP of Manufacturing
Transactions
- Sale
Common Stock
2017-02-28$28.33/sh−8,087$229,130→ 83,387 total - Exercise/Conversion
Common Stock
2017-02-28$7.90/sh+8,087$63,887→ 91,474 total - Exercise/Conversion
Stock Option (right to buy)
2017-02-28−8,087→ 0 totalExercise: $7.90Exp: 2017-06-11→ Common Stock (8,087 underlying)
Holdings
- 12,940
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-10-08→ Common Stock (12,940 underlying) - 24,120
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (24,120 underlying) - 8,087
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-01→ Common Stock (8,087 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $28.41 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Fully exercisable.